United Therapeutics Corp. (UTHR)
524.28
-2.72
(-0.52%)
USD |
NASDAQ |
Mar 20, 16:00
524.42
+0.14
(+0.03%)
After-Hours: 20:00
United Therapeutics Research and Development Expense (Quarterly) : 139.50M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| MannKind Corp. | 27.59M |
| Catalyst Pharmaceuticals, Inc. | 1.807M |
| Zoetis, Inc. | 199.00M |
| Vera Therapeutics, Inc. | 59.18M |
| Geron Corp. | 15.83M |